文献速递脑血管病

年龄≥75岁患者血管内治疗后基线缺血核心体积对卒中结局的意义:7项试验个体患者数据的汇总分析

Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials.
PubMed 文献 · Stroke · 2022-11-07

该研究基于HERMES协作的7项随机试验个体数据,比较年龄<75岁与≥75岁患者基线缺血核心体积(ICV)对血管内治疗(EVT)结局的影响。≥75岁患者EVT组达到mRS≤3所需ICV更小(中位数10.7 mL vs 23.9 mL,P<0.001)。≥75岁患者ICV≥50 mL或≥85 mL时EVT对mRS≤3或≤4的效应可能丧失;ICV≥132 mL为EVT后极差结局高可能性的阈值,但若实现近完全或完全再灌注,ICV 150 mL时EVT仍预测至少30%的mRS≤3率。

要点

  • ≥75岁患者EVT组达到mRS≤3所需ICV中位数为10.7 mL,<75岁组为23.9 mL(P<0.001)。
  • ≥75岁患者ICV<50 mL时EVT对mRS≤3的效应显著(OR 2.38,95%CI 1.35-4.22)。
  • ≥75岁患者ICV≥132 mL为EVT后极差结局高可能性的阈值。

核心结论

  • 基线ICV影响老年患者EVT后卒中结局,但大ICV老年患者若实现近完全或完全再灌注仍可能从EVT获益。
  • 年轻患者似乎无论ICV状态如何均能从EVT获益。

研究设计与样本

  • 基于HERMES协作的7项随机试验个体患者数据的患者水平Meta分析,患者入组时间为2010年12月至2015年4月。
  • 共899例有基线ICV数据的患者,其中247例年龄≥75岁,118例被随机分配至EVT组。
  • ICV通过CT灌注或磁共振弥散加权成像计算。

主要发现

  • ≥75岁患者EVT组达到mRS≤3所需ICV中位数为10.7 mL,<75岁组为23.9 mL(P<0.001)。
  • ≥75岁患者中,两治疗组结局模型显示ICV≥50 mL时EVT对mRS≤3的效应可能丧失,ICV≥85 mL时对mRS≤4的效应可能丧失。
  • ≥75岁患者ICV<50 mL时EVT对mRS≤3的效应显著(OR 2.38,95%CI 1.35-4.22)。
  • ICV≥132 mL为EVT后极差结局高可能性的阈值。
  • 若实现近完全或完全再灌注,ICV 150 mL时EVT仍预测至少30%的mRS≤3率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Age and infarct volume are strong predictors of outcome in patients with ischemic stroke who underwent endovascular therapy (EVT). We aimed to investigate the impact of ischemic core volume (ICV) on stroke outcome after EVT in elderly. METHODS: Using the HERMES (Highly Effective Reperfusion Using Multiple Endovascular Devices) collaboration, a patient-level meta-analysis of 7 randomized trials in which patients were enrolled from December 2010 to April 2015) dataset, we categorized patients into those aged <75 and ≥75 years. ICV was calculated on computed tomography perfusion or magnetic resonance diffusion-weighted imaging. The association between ICV and the benefit of EVT over best medical treatment on outcome (modified Rankin Scale [mRS] at 90 days) and an ICV threshold for high likelihood (≥90%) of very poor outcome (mRS score ≥5) after EVT were investigated. RESULTS: A total of 899 patients who had baseline ICV data, 247 patients aged ≥75 years, of which 118 were randomized in the EVT arm. Patients aged ≥75 years required smaller ICV to achieve mRS score ≤3 than those aged <75 years in the EVT arm (median 10.7 mL versus 23.9 mL, P<0.001). In patients aged ≥75 years, modeling of outcome in both treatment arms revealed potential loss of effect for EVT at ICV of ≥50 mL or ≥85 mL for achieving mRS score ≤3 or ≤4, respectively. Treatment effect of EVT was significant in ICV <50 mL for mRS ≤3 (odds ratio 2.38, 95% confidence interval 1.35-4.22). ICV ≥132 mL was a threshold for high likelihood of very poor outcome after EVT. However, EVT still predicted at least 30% rate of mRS ≤3 at 150 mL ICV if near-complete or complete reperfusion was achieved. CONCLUSIONS: Baseline ICV has an impact on stroke outcome after EVT in the elderly, but elderly patients with large ICV may still benefit from EVT if near-complete or complete reperfusion is achieved. Young patients seem to benefit from EVT regardless of ICV status.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tanaka K, Goyal M, Menon BK, et al. Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials. Stroke. 2022. PMID: 36337054. doi:10.1161/STROKEAHA.122.039774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。